Stephen Barat

516 total citations
19 papers, 368 citations indexed

About

Stephen Barat is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Stephen Barat has authored 19 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 3 papers in Pharmacology. Recurrent topics in Stephen Barat's work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (8 papers) and Fungal Biology and Applications (3 papers). Stephen Barat is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (8 papers) and Fungal Biology and Applications (3 papers). Stephen Barat collaborates with scholars based in United States and United Kingdom. Stephen Barat's co-authors include Katyna Borroto–Esoda, Mahmoud A. Ghannoum, N. Isham, L. Long, Emily L. Larkin, Mohamed S. Abdel‐Rahman, Mohamed S. Abdel‐Rahman, David Angulo, Pamela E. Blackshear and Loretta A. Bober and has published in prestigious journals such as Brain Research, Antimicrobial Agents and Chemotherapy and American Journal of Obstetrics and Gynecology.

In The Last Decade

Stephen Barat

18 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Barat United States 11 234 208 68 67 39 19 368
John C. Vitullo United States 8 193 0.8× 143 0.7× 133 2.0× 36 0.5× 42 1.1× 11 472
E. Jean Cornish United States 10 242 1.0× 152 0.7× 194 2.9× 90 1.3× 27 0.7× 21 529
Hélène Marty France 14 66 0.3× 61 0.3× 110 1.6× 68 1.0× 68 1.7× 40 464
Carolina González‐Cortés Spain 12 96 0.4× 107 0.5× 112 1.6× 10 0.1× 50 1.3× 17 402
S. Dugnani Italy 12 55 0.2× 153 0.7× 202 3.0× 116 1.7× 17 0.4× 29 537
Molly Moloney United States 9 147 0.6× 142 0.7× 186 2.7× 71 1.1× 71 1.8× 9 486
Diane Snowdon United Kingdom 8 48 0.2× 178 0.9× 121 1.8× 18 0.3× 5 0.1× 10 456
Caroline S. Foo Belgium 14 572 2.4× 184 0.9× 312 4.6× 19 0.3× 27 0.7× 17 799
Rapeah Suppıan Malaysia 13 39 0.2× 64 0.3× 135 2.0× 18 0.3× 37 0.9× 38 404

Countries citing papers authored by Stephen Barat

Since Specialization
Citations

This map shows the geographic impact of Stephen Barat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Barat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Barat more than expected).

Fields of papers citing papers by Stephen Barat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Barat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Barat. The network helps show where Stephen Barat may publish in the future.

Co-authorship network of co-authors of Stephen Barat

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Barat. A scholar is included among the top collaborators of Stephen Barat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Barat. Stephen Barat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ghannoum, Mahmoud A., et al.. (2020). Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model. Antimicrobial Agents and Chemotherapy. 64(10). 31 indexed citations
2.
Chu, Sherman, Lisa Long, Thomas S. McCormick, et al.. (2020). A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vivo Activity in a Murine Model of Hematogenously Disseminated Candida albicans. Antimicrobial Agents and Chemotherapy. 65(3). 4 indexed citations
3.
Petraitis, Vidmantas, Rūta Petraitienė, Aspasia Katragkou, et al.. (2020). Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β- d -Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. 64(6). 32 indexed citations
4.
Chu, Sherman, Lisa Long, Thomas S. McCormick, et al.. (2020). A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates. Antimicrobial Agents and Chemotherapy. 65(3). 15 indexed citations
5.
Barat, Stephen, et al.. (2019). Ibrexafungerp, a Novel Oral Antifungal, Demonstrates No Reproductive or Developmental Harm in Preclinical Models [25J]. Obstetrics and Gynecology. 133(1). 114S–114S. 2 indexed citations
6.
Ghannoum, Mahmoud A., L. Long, N. Isham, et al.. (2019). Activity of a Novel 1,3-Beta- d -Glucan Synthase Inhibitor, Ibrexafungerp (Formerly SCY-078), against Candida glabrata. Antimicrobial Agents and Chemotherapy. 63(12). 24 indexed citations
7.
Barat, Stephen, Katyna Borroto–Esoda, Mahmoud A. Ghannoum, Elizabeth L. Berkow, & David Angulo. (2019). 672. Activity of Ibrexafungerp (Formerly SCY-078) Against Candida auris: In vitro, In Vivo, and Clinical Case Studies of Candidemia. Open Forum Infectious Diseases. 6(Supplement_2). S307–S307. 3 indexed citations
8.
Larkin, Emily L., L. Long, N. Isham, et al.. (2019). A Novel 1,3-Beta- d -Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis. Antimicrobial Agents and Chemotherapy. 63(5). 42 indexed citations
9.
Lee, Annie, Brendan Prideaux, Matthew Zimmerman, et al.. (2019). Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model. Antimicrobial Agents and Chemotherapy. 64(3). 21 indexed citations
10.
Ghannoum, Mahmoud A., L. Long, Emily L. Larkin, et al.. (2018). Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis. Antimicrobial Agents and Chemotherapy. 62(6). 64 indexed citations
11.
Carruthers, C., et al.. (2018). SCY-078, a novel IV/oral triterpenoid anti-fungal treatment in development for vulvovaginal candidiasis and other severe invasive fungal infections, is not embryo/feto-toxic. American Journal of Obstetrics and Gynecology. 219(6). 646–647. 3 indexed citations
12.
Barat, Stephen, Katyna Borroto–Esoda, & David Angulo. (2017). SCY-078 Demonstrates Significant Tissue Penetration in Rats and Mice Following Oral or IV Administration. Open Forum Infectious Diseases. 4(suppl_1). S471–S471. 1 indexed citations
13.
Borroto–Esoda, Katyna, Stephen Barat, David Angulo, Kirsty Holden, & Peter Warn. (2017). SCY-078 Demonstrates Significant Antifungal Activity in a Murine Model of Invasive Aspergillosis. Open Forum Infectious Diseases. 4(suppl_1). S472–S472. 10 indexed citations
14.
Losco, Patricia E., Ellen W. Evans, Stephen Barat, et al.. (2004). The Toxicity of SCH 351591, a Novel Phosphodiesterase-4 Inhibitor, in Cynomolgus Monkeys. Toxicologic Pathology. 32(3). 295–308. 51 indexed citations
15.
Barat, Stephen & Mohamed S. Abdel‐Rahman. (1998). Kinetics and rat locomotor activity following cocaine and lidocaine administration. Journal of Applied Toxicology. 18(4). 227–232. 7 indexed citations
16.
Barat, Stephen & Mohamed S. Abdel‐Rahman. (1997). Decreased cocaine- and lidocaine-induced seizure response by dextromethorphan and DNQX in rat. Brain Research. 756(1-2). 179–183. 19 indexed citations
17.
Barat, Stephen, et al.. (1996). Development and Validation of a High-performance Liquid Chromatography Method for the Determination of Cocaine, its Metabolites and Lidocaine. Journal of Applied Toxicology. 16(3). 215–219. 15 indexed citations
18.
Barat, Stephen, et al.. (1996). Cocaine and lidocaine in combination are synergistic convulsants. Brain Research. 742(1-2). 157–162. 24 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John C. Vitullo Breakdown of academic impact, for papers by E. Jean Cornish Breakdown of academic impact, for papers by Hélène Marty Breakdown of academic impact, for papers by Carolina González‐Cortés Breakdown of academic impact, for papers by S. Dugnani Breakdown of academic impact, for papers by Molly Moloney Breakdown of academic impact, for papers by Diane Snowdon Breakdown of academic impact, for papers by Caroline S. Foo Breakdown of academic impact, for papers by Rapeah Suppıan
Rankless by CCL
2026